Phase I dose-escalation study of intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumours

Autor: Van Cutsem, Eric a, ⁎, Khayat, David b, Verslype, Chris a, Billemont, Bertrand c, Tejpar, Sabine a, Meric, Jean-Baptiste d, Soussan-Lazard, Karen e, Assadourian, Sylvie e, Cartot-Cotton, Sylvaine f, Rixe, Olivier g
Zdroj: In European Journal of Cancer January 2013 49(1):17-24
Databáze: ScienceDirect